Trexquant Investment LP Dr Reddys Laboratories LTD Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$64.27 - $69.9 $202,579 - $220,324	3,152 New	3,152 $219,000
Q4 2022 Feb 13, 2023	SELL	$51.15 - $57.45 $74,576 - $83,762	-1,458 Reduced 22.24%	5,099 $263,000
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $834,777 - $958,906	-16,729 Reduced 71.84%	6,557 $343,000
Q2 2022 Aug 11, 2022	BUY	$49.62 - $58.13 $940,001 - $1.1 Million	18,944 Added 436.3%	23,286 $1.29 Million
Q1 2022 May 13, 2022	BUY	$48.27 - $65.25 $209,588 - $283,315	4,342 New	4,342 $242,000
Q1 2019 May 13, 2019	SELL	$35.77 - $40.57 $445,551 - $505,339	-12,456 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$31.89 - $38.44 $397,221 - $478,808	12,456 New	12,456 $470,000
Q3 2018 Nov 09, 2018	SELL	$29.25 - $36.73 $715,396 - $898,342	-24,458 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$28.49 - $35.06 $696,808 - $857,497	24,458 New	24,458 $788,000

253

34.9M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.29B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.